Free Trial
→ China just unlocked Nvidia’s AI chips—what that means for you (From Timothy Sykes) (Ad) Free MBRX Stock Alerts

Moleculin Biotech (MBRX) SEC Filings & 10K Form

Moleculin Biotech logo
$0.67 +0.04 (+5.91%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.66 0.00 (-0.62%)
As of 08/1/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Moleculin Biotech SEC Filings

Export to Excel
DateFilerForm TypeView
08/01/2025
4:13 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
7:25 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2025
4:27 PM		Moleculin Biotech (Filer)
Form 424B5
07/11/2025
4:27 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
4:05 PM		Moleculin Biotech (Filer)
Form DEF 14A
07/08/2025
4:06 PM		Moleculin Biotech (Filer)
Form DEFA14A
06/27/2025
4:25 PM		Moleculin Biotech (Filer)
Form PRE 14A
06/23/2025
3:34 PM		Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:35 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
3:35 PM		Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
8:19 AM		Moleculin Biotech (Filer)
Form 424B4
06/22/2025
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
06/18/2025
8:00 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
8:01 PM		Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
3:19 PM		Moleculin Biotech (Filer)
Form S-1/A
06/11/2025
4:30 PM		Moleculin Biotech (Filer)
Form S-1/A
06/06/2025
8:20 AM		Moleculin Biotech (Filer)
Form S-1/A
06/05/2025
10:01 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
7:45 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
4:15 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
4:24 PM		Moleculin Biotech (Filer)
Form PRE 14A
05/15/2025
2:30 PM		ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
Form SCHEDULE 13G/A
05/14/2025
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
7:40 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
8:00 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
8:00 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
7:45 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
3:42 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
3:31 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
04/01/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:04 PM		Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/24/2025
6:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:05 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:30 PM		Moleculin Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
4:15 PM		Moleculin Biotech (Filer)
Form DEF 14A
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).

Click here for the names of our three top stocks to own this year (no purchase necessary).
03/13/2025
4:15 PM		Moleculin Biotech (Filer)
Form DEF 14A
03/06/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
9:09 AM		Moleculin Biotech (Filer)
Form 424B5
02/24/2025
4:16 PM		Moleculin Biotech (Filer)
Form RW
02/14/2025
4:51 PM		ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
Form SCHEDULE 13G/A
02/13/2025
3:17 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:25 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:25 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
7:31 AM		Moleculin Biotech (Filer)
Form S-1/A
02/10/2025
7:32 AM		Moleculin Biotech (Filer)
Form S-1/A
02/10/2025
7:33 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
8:18 AM		Moleculin Biotech (Filer)
Form S-1/A
01/27/2025
11:08 AM		Moleculin Biotech (Filer)
Form 8-K/A
01/27/2025
8:16 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:02 PM		Moleculin Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
12/03/2024
4:20 PM		Moleculin Biotech (Filer)
Form POS AM
11/18/2024
7:20 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:20 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:35 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
4:09 PM		Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:00 PM		KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:00 PM		Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM		Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM		CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:03 PM		George Robert E. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:04 PM		Climaco John M (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:05 PM		Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
7:06 PM		Moleculin Biotech (Issuer)
Yan Joy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:27 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:43 PM		Moleculin Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/25/2024
3:16 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:40 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:30 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
7:00 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:31 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:15 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
4:15 PM		Moleculin Biotech (Filer)
Form PRE 14A
08/19/2024
3:10 PM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
9:06 AM		Moleculin Biotech (Filer)
Form 424B3
08/16/2024
3:54 PM		Moleculin Biotech (Filer)
Form 424B4
08/15/2024
11:15 PM		Moleculin Biotech (Filer)
Form EFFECT
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).

Click here for the names of our three top stocks to own this year (no purchase necessary).
08/15/2024
10:21 AM		Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
8:57 PM		Moleculin Biotech (Filer)
Form S-1/A
08/14/2024
7:05 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
8:05 AM		Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:MBRX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsored
China just unlocked Nvidia’s AI chips—what that means for you
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...
Timothy Sykes | Sponsored
This Social Security Shift Could Boost Benefits by 400%
If you currently collect Social Security—or plan to in the future—this may be one of the most important update...
InvestorPlace | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored
Jeff Bezos Launches "ChatGPT Killer"?
Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...
Stansberry Research | Sponsored